Logo image of BHR

BRAEMAR HOTELS & RESORTS INC (BHR) Stock Fundamental Analysis

NYSE:BHR - New York Stock Exchange, Inc. - US10482B1017 - REIT - Currency: USD

2.41  +0.11 (+4.78%)

After market: 2.41 0 (0%)

Fundamental Rating

2

BHR gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 129 industry peers in the Diversified REITs industry. BHR may be in some trouble as it scores bad on both profitability and health. BHR has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

BHR had negative earnings in the past year.
In the past year BHR had a positive cash flow from operations.
BHR had negative earnings in each of the past 5 years.
BHR had a positive operating cash flow in 4 of the past 5 years.
BHR Yearly Net Income VS EBIT VS OCF VS FCFBHR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M

1.2 Ratios

The Return On Assets of BHR (-2.72%) is worse than 74.42% of its industry peers.
BHR has a Return On Equity of -8.48%. This is in the lower half of the industry: BHR underperforms 75.19% of its industry peers.
BHR has a worse Return On Invested Capital (1.43%) than 79.07% of its industry peers.
The Average Return On Invested Capital over the past 3 years for BHR is in line with the industry average of 3.15%.
Industry RankSector Rank
ROA -2.72%
ROE -8.48%
ROIC 1.43%
ROA(3y)-2.05%
ROA(5y)-3.03%
ROE(3y)-5.99%
ROE(5y)-11.2%
ROIC(3y)2.18%
ROIC(5y)N/A
BHR Yearly ROA, ROE, ROICBHR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30

1.3 Margins

With a Operating Margin value of 4.81%, BHR is not doing good in the industry: 86.05% of the companies in the same industry are doing better.
In the last couple of years the Operating Margin of BHR has declined.
Looking at the Gross Margin, with a value of 68.81%, BHR is in line with its industry, outperforming 55.81% of the companies in the same industry.
In the last couple of years the Gross Margin of BHR has remained more or less at the same level.
Industry RankSector Rank
OM 4.81%
PM (TTM) N/A
GM 68.81%
OM growth 3Y290.5%
OM growth 5Y-7.45%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.38%
GM growth 5Y-0.18%
BHR Yearly Profit, Operating, Gross MarginsBHR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

0

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BHR is destroying value.
Compared to 1 year ago, BHR has about the same amount of shares outstanding.
BHR has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, BHR has a worse debt to assets ratio.
BHR Yearly Shares OutstandingBHR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
BHR Yearly Total Debt VS Total AssetsBHR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

Based on the Altman-Z score of 0.12, we must say that BHR is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.12, BHR is not doing good in the industry: 71.32% of the companies in the same industry are doing better.
BHR has a Debt/Equity ratio of 1.79. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.79, BHR is doing worse than 68.22% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.79
Debt/FCF N/A
Altman-Z 0.12
ROIC/WACC0.18
WACC7.91%
BHR Yearly LT Debt VS Equity VS FCFBHR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

A Current Ratio of 0.79 indicates that BHR may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.79, BHR is doing worse than 60.47% of the companies in the same industry.
BHR has a Quick Ratio of 0.79. This is a bad value and indicates that BHR is not financially healthy enough and could expect problems in meeting its short term obligations.
BHR's Quick ratio of 0.76 is in line compared to the rest of the industry. BHR outperforms 40.31% of its industry peers.
Industry RankSector Rank
Current Ratio 0.79
Quick Ratio 0.76
BHR Yearly Current Assets VS Current LiabilitesBHR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 23.21% over the past year.
Looking at the last year, BHR shows a decrease in Revenue. The Revenue has decreased by -2.42% in the last year.
The Revenue has been growing by 8.36% on average over the past years. This is quite good.
EPS 1Y (TTM)23.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-180%
Revenue 1Y (TTM)-2.42%
Revenue growth 3Y19.44%
Revenue growth 5Y8.36%
Sales Q2Q%-1.49%

3.2 Future

The Earnings Per Share is expected to decrease by -39.80% on average over the next years. This is quite bad
The Revenue is expected to decrease by -0.09% on average over the next years.
EPS Next Y-113.81%
EPS Next 2Y-39.8%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-2.52%
Revenue Next 2Y-0.09%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BHR Yearly Revenue VS EstimatesBHR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M
BHR Yearly EPS VS EstimatesBHR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -1 -2 -3

1

4. Valuation

4.1 Price/Earnings Ratio

BHR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year BHR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BHR Price Earnings VS Forward Price EarningsBHR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BHR indicates a rather cheap valuation: BHR is cheaper than 85.27% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.69
BHR Per share dataBHR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

BHR's earnings are expected to decrease with -39.80% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-39.8%
EPS Next 3YN/A

5

5. Dividend

5.1 Amount

BHR has a Yearly Dividend Yield of 8.51%, which is a nice return.
BHR's Dividend Yield is rather good when compared to the industry average which is at 6.69. BHR pays more dividend than 83.72% of the companies in the same industry.
BHR's Dividend Yield is rather good when compared to the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 8.51%

5.2 History

The dividend of BHR decreases each year by -5.40%.
BHR has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of BHR decreased in the last 3 years.
Dividend Growth(5Y)-5.4%
Div Incr Years0
Div Non Decr Years2
BHR Yearly Dividends per shareBHR Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

The earnings of BHR are negative and hence is the payout ratio. BHR will probably not be able to sustain this dividend level.
The Dividend Rate of BHR has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP-88.82%
EPS Next 2Y-39.8%
EPS Next 3YN/A
BHR Yearly Income VS Free CF VS DividendBHR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100M -200M

BRAEMAR HOTELS & RESORTS INC

NYSE:BHR (6/6/2025, 8:04:00 PM)

After market: 2.41 0 (0%)

2.41

+0.11 (+4.78%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)05-08 2025-05-08/amc
Earnings (Next)07-29 2025-07-29
Inst Owners50.9%
Inst Owner Change-4.99%
Ins Owners1.3%
Ins Owner Change29.77%
Market Cap161.59M
Analysts46.67
Price Target2.04 (-15.35%)
Short Float %1.73%
Short Ratio3.15
Dividend
Industry RankSector Rank
Dividend Yield 8.51%
Yearly Dividend0.77
Dividend Growth(5Y)-5.4%
DP-88.82%
Div Incr Years0
Div Non Decr Years2
Ex-Date06-30 2025-06-30 (0.05)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)25.25%
Min EPS beat(2)-13.5%
Max EPS beat(2)64%
EPS beat(4)2
Avg EPS beat(4)24.46%
Min EPS beat(4)-48.51%
Max EPS beat(4)95.87%
EPS beat(8)4
Avg EPS beat(8)23.64%
EPS beat(12)5
Avg EPS beat(12)-1.86%
EPS beat(16)8
Avg EPS beat(16)28.57%
Revenue beat(2)2
Avg Revenue beat(2)3.4%
Min Revenue beat(2)2.98%
Max Revenue beat(2)3.83%
Revenue beat(4)3
Avg Revenue beat(4)0.54%
Min Revenue beat(4)-4.99%
Max Revenue beat(4)3.83%
Revenue beat(8)6
Avg Revenue beat(8)-0.17%
Revenue beat(12)9
Avg Revenue beat(12)1.35%
Revenue beat(16)13
Avg Revenue beat(16)3.31%
PT rev (1m)0%
PT rev (3m)-33.33%
EPS NQ rev (1m)-2.56%
EPS NQ rev (3m)4.76%
EPS NY rev (1m)-3.82%
EPS NY rev (3m)-5.16%
Revenue NQ rev (1m)-2.69%
Revenue NQ rev (3m)-3.14%
Revenue NY rev (1m)0.41%
Revenue NY rev (3m)0.48%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.22
P/FCF N/A
P/OCF 3.52
P/B 0.24
P/tB 0.24
EV/EBITDA 9.69
EPS(TTM)-0.86
EYN/A
EPS(NY)-1.5
Fwd EYN/A
FCF(TTM)-0.25
FCFYN/A
OCF(TTM)0.68
OCFY28.42%
SpS10.81
BVpS10.03
TBVpS9.99
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.72%
ROE -8.48%
ROCE 1.81%
ROIC 1.43%
ROICexc 1.49%
ROICexgc 1.51%
OM 4.81%
PM (TTM) N/A
GM 68.81%
FCFM N/A
ROA(3y)-2.05%
ROA(5y)-3.03%
ROE(3y)-5.99%
ROE(5y)-11.2%
ROIC(3y)2.18%
ROIC(5y)N/A
ROICexc(3y)2.37%
ROICexc(5y)N/A
ROICexgc(3y)2.4%
ROICexgc(5y)N/A
ROCE(3y)2.76%
ROCE(5y)N/A
ROICexcg growth 3Y336.52%
ROICexcg growth 5Y-3.32%
ROICexc growth 3Y337.41%
ROICexc growth 5Y-3.32%
OM growth 3Y290.5%
OM growth 5Y-7.45%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.38%
GM growth 5Y-0.18%
F-Score5
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity 1.79
Debt/FCF N/A
Debt/EBITDA 9.14
Cap/Depr 64.7%
Cap/Sales 8.63%
Interest Coverage 0.34
Cash Conversion 34.91%
Profit Quality N/A
Current Ratio 0.79
Quick Ratio 0.76
Altman-Z 0.12
F-Score5
WACC7.91%
ROIC/WACC0.18
Cap/Depr(3y)223.65%
Cap/Depr(5y)152.9%
Cap/Sales(3y)26.8%
Cap/Sales(5y)20.36%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)23.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-180%
EPS Next Y-113.81%
EPS Next 2Y-39.8%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.42%
Revenue growth 3Y19.44%
Revenue growth 5Y8.36%
Sales Q2Q%-1.49%
Revenue Next Year-2.52%
Revenue Next 2Y-0.09%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-47.43%
EBIT growth 3Y366.41%
EBIT growth 5Y0.29%
EBIT Next Year55.46%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y91.74%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-62.66%
OCF growth 3Y1.45%
OCF growth 5Y0.16%